Journal
ANNALS OF ONCOLOGY
Volume 20, Issue 12, Pages 1907-1912Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdp369
Keywords
adverse effects; drug interactions; drug therapy; neoplasms
Categories
Ask authors/readers for more resources
Methods: We searched PubMed for eligible articles and on-line databases for abstracts of major oncology meetings. Results: Eight studies reported on the frequency of DDIs: six evaluated the frequency of potential DDIs, while two studies reported on real DDIs, i.e. interactions that had clinical consequences. Studies of potential DDIs found that approximately one-third of patients are exposed to dangerous drug doublets, with the most common ones involving warfarin and anticonvulsants. One study of real DDIs found that 2% of hospitalized cancer patients had a DDI as the cause of admission. Conclusions: Drug interactions comprise an important issue in oncology, with approximately one-third of ambulatory cancer patients being at risk of DDIs. Data are limited on the clinical consequences of drug interactions among cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available